Skip to main content
. 2022 May 25;12:873516. doi: 10.3389/fonc.2022.873516

Figure 3.

Figure 3

Immunohistochemical profile of a prostate adenocarcinoma specimen, showing positive staining for androgen receptor (AR, nuclear), PDHA1 and PDP1 (cytoplasmic), and negative for PDP2. Magnification: X400.